TABLE 2.
Specimens Collected for Culture, Positive for Neisseria gonorrhoeae, and With Elevated Azithromycin, Ceftriaxone, and/or Cefixime MICsby Anatomic Site, SURRG, 2018–2019
| Urethral/Urine* |
Endocervical/Vaginal |
Rectal |
Pharyngeal |
Total |
|||||
|---|---|---|---|---|---|---|---|---|---|
| n | Row % | n | Row % | n | Row % | n | Row % | n | |
|
| |||||||||
| Specimens collected | 14,781 | 25.3 | 12,781 | 21.9 | 8848 | 15.1 | 22,031 | 37.7 | 58,441 |
| Specimens positive for N. gonorrhoeae | 6735 | 62.3 | 852 | 7.9 | 1673 | 15.5 | 1554 | 14.4 | 10,814 |
| Isolates with AST performed | 6712 | 62.5 | 849 | 7.9 | 1646 | 15.3 | 1528 | 14.2 | 10,735 |
| Azithromycin MIC ≥2.0 μg/mL† | 671 | 56.6 | 47 | 4.0 | 244 | 20.6 | 223 | 18.8 | 1185 |
| Ceftriaxone MIC ≥0.125 μg/mL† | 26 | 59.1 | 1 | 2.3 | 4 | 9.1 | 13 | 29.6 | 44 |
| Cefixime MIC ≥0.250 μg/mL† | 22 | 53.7 | 2 | 4.9 | 10 | 24.4 | 7 | 17.1 | 41 |
*
19 of 14,781 urethral/urine specimens collected for culture were urine.
†
Isolates may have elevated MICs (via Etest) to >1 antibiotic; includes multiple isolates from the same individual from different anatomic sites.